Endres, M <br/><br/>
Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Jul 1998 
 - 8880-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0027-8424 
<br/><br/><label>Standard No.: </label>10.1073/pnas.95.15.8880  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anticholesteremic Agents--pharmacology<br/>Cells, Cultured<br/>Diterpenes--antagonists & inhibitors<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Ischemic Attack, Transient--pathology<br/>Lovastatin--pharmacology<br/>Mice<br/>Mice, Inbred C57BL<br/>Nitric Oxide Synthase--metabolism<br/>Nitric Oxide Synthase Type II<br/>Nitric Oxide Synthase Type III<br/>Simvastatin--pharmacology<br/>Tumor Cells, Cultured<br/>Up-Regulation